
Raymond U. Osarogiagbon, MD, FACP, discusses the long-term effects of the COVID-19 pandemic on lung cancer screenings.

Your AI-Trained Oncology Knowledge Connection!


Raymond U. Osarogiagbon, MD, FACP, discusses the long-term effects of the COVID-19 pandemic on lung cancer screenings.

Raymond U. Osarogiagbon, MD, FACP, discusses geographic disparities in lung cancer.

Raymond U. Osarogiagbon, MD, discusses geographic disparities in lung cancer mortality rates across the United States.

Raymond U. Osarogiagbon, MD, FACP, Boston Baskin Cancer Foundation, Baptist Memorial Medical Group, discusses treating patients with lung cancer that have the potential to be cured.

Published: January 26th 2022 | Updated:

Published: September 11th 2021 | Updated:

Published: November 23rd 2016 | Updated: